Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeThe kallikrein-kinin system in diabetic nephropathyThe role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP)Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitusLack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic miceLoss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice.The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease.Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction.Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin systemThe kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy.The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimersThe kallikrein-kinin system in health and in diseases of the kidney.Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling.Targeting the 'Janus face' of the B2-bradykinin receptor.Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes.
P2860
Q24306614-0B0DC530-3CF8-4631-9293-0DBFEC42E0C1Q26827473-3D8514BA-C6AE-4081-8A44-80900CCBB433Q28584037-E8491C95-B126-4F47-8EAB-0C60BBE89DFCQ33897901-294D06B5-70DD-4EF6-8699-F1E56866C127Q33933352-5E1BBF6C-CB6F-4845-9F4F-4884AC170725Q34132504-1848BD85-F515-437F-BB3A-F5432C87C731Q35117065-6AB26729-EF77-45CF-B058-CB4966450C69Q36121736-C316BF20-E0B9-4612-A04D-E866CB03437AQ36296024-A441D5C8-6BB0-4B47-B900-444699C996AEQ36404461-7C6643E6-533A-4F4F-BC2C-12026C80CAA2Q36967299-9965A731-7315-4ECE-A5E0-DB4261B312C1Q37070150-4624985B-78B3-4545-A9DD-E4DBBCC76ED2Q37193691-42847F6E-9E55-4D62-BD39-A8793F4723C8Q37216578-F37CA345-B1AF-49E9-B766-3BDB6B237A45Q38129928-54726FB0-78EB-47BD-827C-AD6E608CEFEDQ48162668-755F7738-59C0-47AA-9D7A-04D006B20369
P2860
Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Regulation of cardiac bradykin ...... erload-induced cardiomyopathy.
@ast
Regulation of cardiac bradykin ...... erload-induced cardiomyopathy.
@en
type
label
Regulation of cardiac bradykin ...... erload-induced cardiomyopathy.
@ast
Regulation of cardiac bradykin ...... erload-induced cardiomyopathy.
@en
prefLabel
Regulation of cardiac bradykin ...... erload-induced cardiomyopathy.
@ast
Regulation of cardiac bradykin ...... erload-induced cardiomyopathy.
@en
P2093
P1476
Regulation of cardiac bradykin ...... erload-induced cardiomyopathy.
@en
P2093
Carsten Tschöpe
Christine Altmann
Dirk Westermann
Heinz-Peter Schultheiss
Marcos Barbosa
Michael Scheeler
Thomas Walther
P304
P356
10.1016/S1567-5769(02)00174-1
P577
2002-12-01T00:00:00Z